Journal of Clinical Pediatrics >
Factors related to bronchiolitis obliterans syndrome in pediatric patients survived longer than 100 days after hematopoietic stem cell transplantation
Received date: 2022-11-17
Online published: 2024-02-02
Objective To analyse the clinical characteristics and risk factors of occlusive bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children in order to further optimize the treatment protocol.Methods Clinical data of children who received allo-HSCT from October 2010 to December 2018 at Children's Hospital of Soochow University were retrospectively analysed. Results A total of 351 children were included, 213 males and 138 females. Until September 1, 2019, a total of 29 (8.3%) children developed BOS, 11 males and 18 females, with a median age of 92.0 (67.0-132.0) months. The median time from transplantation to the development of BOS was 10.0 (8.5-20.0) months. The cumulative incidence of BOS at 1, 2, and 3 years after transplantation was (6.0±1.3)%, (10.0±1.8)%, and (10.7±2.0)%, respectively. 28 of the 29 children with BOS had comorbidities with chronic graft-versus-host disease (cGVHD) in other target organs prior to the onset of BOS. The results of multifactorial logistic regression analysis showed that older age, female gender, respiratory disease within 100 days after transplantation, and comorbidities with other target organ cGVHD were independent risk factors for the development of BOS (P<0.05). Conclusion BOS is a serious complication after HSCT. Children who were female, older, had a combination of other target organ cGVHD, and had respiratory disease within 100 days of transplantation were at greater risk of developing BOS.
Ruonan SUN , Bohan LI , Defei ZHENG , Xiaying ZHAO , Ziyun LIN , Yixin HU , Li GAO , Jing GAO , Jie LI , Jun LU , Peifang XIAO , Jian PAN , Jing LING , Fang FANG , Shaoyan HU . Factors related to bronchiolitis obliterans syndrome in pediatric patients survived longer than 100 days after hematopoietic stem cell transplantation[J]. Journal of Clinical Pediatrics, 2024 , 42(2) : 139 -145 . DOI: 10.12372/jcp.2024.22e1533
| [1] | Wang X, Huang R, Zhang X, et al. Current status and prospects of hematopoietic stem cell transplantation in China[J]. Chin Med J (Engl), 2022, 135(12): 1394-1403. |
| [2] | Glanville AR, Benden C, Bergeron A, et al. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions[J]. ERJ Open Res, 2022, 8(3): 00185-2022. |
| [3] | Haider S, Durairajan N, Soubani AO. Noninfectious pulmonary complications of haematopoietic stem cell transplantation[J]. Eur Respir Rev, 2020, 29(156): 190119. |
| [4] | Jung S, Yoon HM, Yoon J, et al. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation[J]. Pediatr Pulmonol, 2021, 56(10): 3332-3341. |
| [5] | Walther S, Rettinger E, Maurer HM, et al. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation[J]. Pediatr Pulmonol, 2020, 55(7): 1725-1735. |
| [6] | Martin PJ, Weisdorf D, Przepiorka D, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report[J]. Biol Blood Marrow Transplant, 2015, 21(8): 1343-1359. |
| [7] | Jagasia MH, Greinix HT, Arora M, et al. National Institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report[J]. Biol Blood Marrow Transplant, 2015, 21(3): 389-401. |
| [8] | Roca J, Gra?e?a A, Rodriguez-Roisin R, et al. Fatal airway disease in an adult with chronic graft-versus-host disease[J]. Thorax, 1982, 37(1): 77-78. |
| [9] | Pandolfi L, Fusco R, Frangipane V, et al. Loading Imatinib inside targeted nanoparticles to prevent bronchiolitis obliterans syndrome[J]. Sci Rep, 2020, 10(1): 20726. |
| [10] | Bos S, Beeckmans H, Vanstapel A, et al. Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?[J]. Lancet Respir Med, 2022, 10(8): 796-810. |
| [11] | Kemp R, Pustulka I, Boerner G, et al. Relationship between FEV(1) decline and mortality in patients with bronchiolitis obliterans syndrome-a systematic literature review[J]. Respir Med, 2021, 188: 106608. |
| [12] | Kavaliunaite E, Aurora P. Diagnosing and managing bronchiolitis obliterans in children[J]. Expert Rev Respir Med, 2019, 13(5): 481-488. |
| [13] | Sheshadri A, Sacks NC, Healey BE, et al. Lung function monitoring after lung transplantation and allogeneic hematopoietic stem cell transplantation[J]. Clin Ther, 2022, 44(5): 755-765. |
| [14] | Yoshihara S, Yanik G, Cooke KR, et al. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2007, 13(7): 749-759. |
| [15] | Dudek AZ, Mahaseth H, DeFor TE, et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes[J]. Biol Blood Marrow Transplant, 2003, 9(10): 657-666. |
| [16] | Chien JW, Duncan S, Williams KM, et al. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease[J]. Biol Blood Marrow Transplant, 2010, 16(1 Suppl): S106-114. |
| [17] | Chien JW. Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation[J]. Expert Rev Respir Med, 2011, 5(1): 127-135. |
| [18] | Au BK, Au MA, Chien JW. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2011, 17(7): 1072-1078. |
| [19] | Gazourian L, Rogers AJ, Ibanga R, et al. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation[J]. Am J Hematol, 2014, 89(4): 404-409. |
| [20] | Alkhunaizi M, Patel B, Bueno L, et al. Risk factors for bronchiolitis obliterans syndrome after initial detection of pulmonary impairment after hematopoietic cell transplantation[J]. Transplant Cell Ther, 2022, 29(3):204-204. |
| [21] | Grube M, Holler E, Weber D, et al. Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study[J]. Biol Blood Marrow Transplant, 2016, 22(10): 1781-1791. |
| [22] | Abedin S, Yanik GA, Braun T, et al. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung[J]. Biol Blood Marrow Transplant, 2015, 21(6): 1127-1131. |
| [23] | Hamilton BK. Updates in chronic graft-versus-host disease[J]. Hematology Am Soc Hematol Educ Program, 2021, 2021(1): 648-654. |
| [24] | Zhang M, Zhang S. T cells in fibrosis and fibrotic diseases[J]. Front Immunol, 2020, 11:1142. |
| [25] | Jiang H, Fu D, Bidgoli A, et al. T cell subsets in graft versus host disease and graft versus tumor[J]. Front Immunol, 2021, 12:761448. |
| [26] | Crossland RE, Perutelli F, Bogunia-Kubik K, et al. Potential novel biomarkers in chronic graft-versus-host disease[J]. Front Immunol, 2020, 11:602547. |
| [27] | Flynn R, Du J, Veenstra RG, et al. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans[J]. Blood, 2014, 123(25): 3988-3998. |
| [28] | Santo Tomas LH, Loberiza FR Jr, Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia[J]. Chest, 2005, 128(1): 153-161. |
| [29] | Gunn ML, Godwin JD, Kanne JP, et al. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation[J]. J Thorac Imaging, 2008, 23(4): 244-250. |
| [30] | 庄娟, 顾斌, 柯鹏, 等. 单倍型造血干细胞移植后闭塞性细支气管炎综合征的临床分析[J]. 中华血液学杂志, 2019, 40(5): 404-410. |
| [31] | 范祎, 李飞, 王秀丽, 等. 异基因造血干细胞移植后慢性移植物抗宿主病: 移植前肺功能对肺部受累的预测作用[J]. 中国血液流变学杂志, 2017, 27(3): 241-246. |
| [32] | Vieira AG, Funke VA, Nunes EC, et al. Bronchiolitis obliterans in patients undergoing allogeneic hematopoietic SCT[J]. Bone Marrow Transplant, 2014, 49(6): 812-817. |
/
| 〈 |
|
〉 |
